ATL1 and hereditary spastic paraplegia: Though the detailed mechanisms by which ATL1 mutations impair LDs and cholesterol trafficking await further investigation, our data point to a new target to treat axonal defects in HSP through regulating glial cells to restore cholesterol homeostasis.